Towards novel anti-cancer strategies based on cystatin function - PubMed (original) (raw)
Review
Towards novel anti-cancer strategies based on cystatin function
Daniel Keppler. Cancer Lett. 2006.
Abstract
Cystatins have recently emerged as important players in a multitude of physiological and patho-physiological settings that range from cell survival and proliferation, to differentiation, cell signaling and immunomodulation. This group of cysteine protease inhibitors forms a large super-family of proteins composed of one, two, three, and, in some species, more than three cystatin domains. Over the last 20 years or so, members of the cystatin super-family have been primarily explored with respect to their capacity to inhibit intracellular cysteine proteases. Yet, this classical mode of action does not fully explain their remarkably diverse biological functions. Due to the space limitations, the author will discuss here the most recent findings that suggest that some of the single-domain, cytoplasmic and cell-secreted cystatins may play important roles in the promotion or suppression of tumor growth, invasion and metastasis. Based on the present understanding of cystatin function, novel avenues for anti-cancer strategies are proposed.
Similar articles
- Cystatins--Extra- and intracellular cysteine protease inhibitors: High-level secretion and uptake of cystatin C in human neuroblastoma cells.
Wallin H, Bjarnadottir M, Vogel LK, Wassélius J, Ekström U, Abrahamson M. Wallin H, et al. Biochimie. 2010 Nov;92(11):1625-34. doi: 10.1016/j.biochi.2010.08.011. Epub 2010 Aug 25. Biochimie. 2010. PMID: 20800088 - Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression.
Calkins CC, Sloane BF. Calkins CC, et al. Biol Chem Hoppe Seyler. 1995 Feb;376(2):71-80. Biol Chem Hoppe Seyler. 1995. PMID: 7794528 Review. - Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis.
Werle B, Schanzenbächer U, Lah TT, Ebert E, Jülke B, Ebert W, Fiehn W, Kayser K, Spiess E, Abrahamson M, Kos J. Werle B, et al. Oncol Rep. 2006 Oct;16(4):647-55. Oncol Rep. 2006. PMID: 16969475 - Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain.
Díaz BG, Gross S, Assfalg-Machleidt I, Pfeiler D, Gollmitzer N, Gabrijelcic-Geiger D, Stubbs MT, Fritz H, Auerswald EA, Machleidt W. Díaz BG, et al. Biol Chem. 2001 Jan;382(1):97-107. doi: 10.1515/BC.2001.015. Biol Chem. 2001. PMID: 11258679 - Role of cystatins in tumor neovascularization.
Keppler D, Sierra F. Keppler D, et al. Future Oncol. 2005 Oct;1(5):661-72. doi: 10.2217/14796694.1.5.661. Future Oncol. 2005. PMID: 16556043 Review.
Cited by
- Developmental regulation of synthesis and dimerization of the amyloidogenic protease inhibitor cystatin C in the hematopoietic system.
Xu Y, Lindemann P, Vega-Ramos J, Zhang JG, Villadangos JA. Xu Y, et al. J Biol Chem. 2014 Apr 4;289(14):9730-40. doi: 10.1074/jbc.M113.538041. Epub 2014 Feb 25. J Biol Chem. 2014. PMID: 24570004 Free PMC article. - Cystatin A suppresses tumor cell growth through inhibiting epithelial to mesenchymal transition in human lung cancer.
Ma Y, Chen Y, Li Y, Grün K, Berndt A, Zhou Z, Petersen I. Ma Y, et al. Oncotarget. 2017 Dec 20;9(18):14084-14098. doi: 10.18632/oncotarget.23505. eCollection 2018 Mar 6. Oncotarget. 2017. PMID: 29581829 Free PMC article. - Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia.
Mohanty S, Jyotsana N, Sharma A, Kloos A, Gabdoulline R, Othman B, Lai CK, Schottmann R, Mandhania M, Schmoellerl J, Grebien F, Ramsay E, Thomas A, Vornlocher HP, Ganser A, Thol F, Heuser M. Mohanty S, et al. Cancers (Basel). 2020 Sep 26;12(10):2766. doi: 10.3390/cancers12102766. Cancers (Basel). 2020. PMID: 32993115 Free PMC article. - Cystatin M/E (Cystatin 6): A Janus-Faced Cysteine Protease Inhibitor with Both Tumor-Suppressing and Tumor-Promoting Functions.
Lalmanach G, Kasabova-Arjomand M, Lecaille F, Saidi A. Lalmanach G, et al. Cancers (Basel). 2021 Apr 14;13(8):1877. doi: 10.3390/cancers13081877. Cancers (Basel). 2021. PMID: 33919854 Free PMC article. Review. - The preoperative serum cystatin-C as an independent prognostic factor for survival in upper tract urothelial carcinoma.
Tan P, Shi M, Chen J, Xu H, Xie N, Xu H, Jiang Y, Ai JZ, Liu LR, Yang L, Wei Q. Tan P, et al. Asian J Androl. 2019 Mar-Apr;21(2):163-169. doi: 10.4103/aja.aja_84_18. Asian J Androl. 2019. PMID: 30416134 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous